Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.

CDMOP

Avid Bioservices (CDMOP)

Avid Bioservices Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:CDMOP
DataHoraFonteTítuloCódigoCompanhia
29/06/202217:05GlobeNewswire Inc.Avid Bioservices Reports Financial Results for Fourth Quarter and Full Fiscal Year Ended April 30, 2022 and Recent DevelopmentsNASDAQ:CDMOPAvid Bioservices Inc
28/06/202220:38Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CDMOPAvid Bioservices Inc
22/06/202217:05GlobeNewswire Inc.Avid Bioservices to Report Financial Results for Quarter and Fiscal Year Ended April 30, 2022 After Market Close on June 29, 2022NASDAQ:CDMOPAvid Bioservices Inc
14/06/202209:05GlobeNewswire Inc.Avid Bioservices Announces Launch of Analytical and Process Development Suites Within New, World-Class Viral Vector Development and Manufacturing FacilityNASDAQ:CDMOPAvid Bioservices Inc
13/06/202209:05GlobeNewswire Inc.Avid Bioservices Announces Further Expansion of Process Development Capacity for Mammalian Cell BusinessNASDAQ:CDMOPAvid Bioservices Inc
16/03/202217:05GlobeNewswire Inc.Avid Bioservices to Participate in KeyBanc Capital Markets Life Sciences & MedTech ForumNASDAQ:CDMOPAvid Bioservices Inc
08/03/202218:38Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:CDMOPAvid Bioservices Inc
08/03/202218:26Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CDMOPAvid Bioservices Inc
08/03/202218:09GlobeNewswire Inc.Avid Bioservices Reports Financial Results for Third Quarter Ended January 31, 2022 and Recent DevelopmentsNASDAQ:CDMOPAvid Bioservices Inc
01/03/202218:05GlobeNewswire Inc.Avid Bioservices to Report Financial Results for Third Quarter of Fiscal Year 2022 after Market Close on March 8, 2022NASDAQ:CDMOPAvid Bioservices Inc
10/02/202214:52Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:CDMOPAvid Bioservices Inc
09/02/202211:10Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:CDMOPAvid Bioservices Inc
10/01/202210:05GlobeNewswire Inc.Avid Bioservices Announces Official Opening of Second Downstream Processing Suite Within Myford North FacilityNASDAQ:CDMOPAvid Bioservices Inc
07/12/202118:05GlobeNewswire Inc.Avid Bioservices Reports Financial Results for Second Quarter Ended October 31, 2021 and Recent DevelopmentsNASDAQ:CDMOPAvid Bioservices Inc
30/11/202118:05GlobeNewswire Inc.Avid Bioservices to Report Financial Results for Second Quarter of Fiscal Year 2022 After Market Close on December 7, 2021NASDAQ:CDMOPAvid Bioservices Inc
04/11/202109:05GlobeNewswire Inc.Avid Bioservices Appoints Elie G. Hanania, Ph.D., as Vice President, Process Development, Viral Vector TechnologiesNASDAQ:CDMOPAvid Bioservices Inc
26/10/202109:05GlobeNewswire Inc.Avid Bioservices to Join S&P SmallCap 600 IndexNASDAQ:CDMOPAvid Bioservices Inc
14/10/202109:05GlobeNewswire Inc.Avid Bioservices Announces Expansion into Viral Vector Development and Manufacturing Services for Cell and Gene TherapyNASDAQ:CDMOPAvid Bioservices Inc
07/10/202109:05GlobeNewswire Inc.Avid Bioservices Appoints Matthew Kwietniak as Chief Commercial OfficerNASDAQ:CDMOPAvid Bioservices Inc
08/09/202117:05GlobeNewswire Inc.Avid Bioservices Reports Financial Results for First Quarter Ended July 31, 2021 and Recent DevelopmentsNASDAQ:CDMOPAvid Bioservices Inc
02/09/202117:05GlobeNewswire Inc.Avid Bioservices to Participate at Upcoming Investor ConferencesNASDAQ:CDMOPAvid Bioservices Inc
01/09/202117:05GlobeNewswire Inc.Avid Bioservices to Report Financial Results for First Quarter of Fiscal Year 2022 After Market Close on September 8, 2021NASDAQ:CDMOPAvid Bioservices Inc
27/08/202119:02Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:CDMOPAvid Bioservices Inc
02/07/202118:51Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:CDMOPAvid Bioservices Inc
01/07/202109:05GlobeNewswire Inc.Avid Bioservices Announces Appointment of Esther M. Alegria, Ph.D., to Board of DirectorsNASDAQ:CDMOPAvid Bioservices Inc
29/06/202117:45Edgar (US Regulatory)Annual Report (10-k)NASDAQ:CDMOPAvid Bioservices Inc
29/06/202117:05GlobeNewswire Inc.Avid Bioservices Reports Financial Results for Fourth Quarter and Fiscal Year Ended April 30, 2021 and Recent DevelopmentsNASDAQ:CDMOPAvid Bioservices Inc
22/06/202117:05GlobeNewswire Inc.Avid Bioservices to Report Financial Results For Quarter and Fiscal Year Ended April 30, 2021 After Market Close on June 29, ...NASDAQ:CDMOPAvid Bioservices Inc
25/05/202109:05GlobeNewswire Inc.Avid Bioservices to Serve as Commercial Manufacturer for ADC Therapeutics’ ZYNLONTA™ (Loncastuximab Tesirine-Lpyl)NASDAQ:CDMOPAvid Bioservices Inc
15/04/202117:05GlobeNewswire Inc.Avid Bioservices Announces Completion of Redemption of Series E Convertible Preferred StockNASDAQ:CDMOPAvid Bioservices Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:CDMOP